Cite

HARVARD Citation

    Avouac, J. et al. (2021). COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. Lancet. pp. e419-e426. [Online]. 
  
Back to record